Nagoya, Japan

Keizo Nakaya

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keizo Nakaya. Retrieved from https://idiyas.com/inventor/keizo-nakaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keizo Nakaya: Innovator in Diabetes Treatment

Introduction

Keizo Nakaya is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. His innovative approach focuses on the combination of existing diabetic medications to enhance their effectiveness.

Latest Patents

One of Nakaya's notable patents is for a medicine that consists of the concomitant use or combination of a DPP-IV inhibitor and other diabetic medicines. The primary problem addressed by this invention is the need for a treatment that is effective for type 2 diabetes, diabetic complications, or impaired glucose tolerance. The patent provides a solution by offering a medicine characterized by a specific compound and at least one other diabetic medication.

Career Highlights

Throughout his career, Nakaya has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has worked on various innovative projects. His dedication to improving diabetes treatment has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Nakaya has collaborated with several talented individuals in his field, including Moritaka Goto and Satoko Yamashita. These partnerships have contributed to the advancement of his research and the development of effective medical solutions.

Conclusion

Keizo Nakaya's work in the field of diabetes treatment exemplifies the impact of innovation in medicine. His patent for a combination therapy highlights the potential for improved patient outcomes in managing diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…